Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huub C Gelderblom

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Frontiers in Pediatrics|July 8, 2026
Breaking the sound barrier: global monoclonal antibody pharmacoequityHuub C Gelderblom, Glenda Gray, Brian Kelley
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 30, 2010
Transient reappearance of serum hepatitis C virus RNA observed by real-time PCR during antiviral therapy with peginterferon and ribavirin: Reappearance of references published in 2005-2009Huub C Gelderblom, Marcel G H M Beld
Journal of the International AIDS Society|May 17, 2024
The potential of broadly neutralizing antibodies for HIV preventionHuub C Gelderblom, Lawrence Corey, Dan H Barouch
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 30, 2007
Hepatitis C virus RNA quantification by the COBAS AmpliPrep/COBAS TaqMan System: averages do not tell the whole storyHuub C Gelderblom, Marcel G H M Beld
Plos Neglected Tropical Diseases|March 24, 2015
Mass drug administration for trachoma: how long is not long enough?Violeta Jimenez, Huub C Gelderblom, Rebecca Mann Flueckiger, et al.
Plos One|April 6, 2016
Diagnostic Accuracy of the HemoCue Hb 301, STAT-Site MHgb and URIT-12 Point-of-Care Hemoglobin Meters in a Central Laboratory and a Community Based Clinic in Durban, South AfricaManjeetha Jaggernath, Rumallen Naicker, Savathree Madurai, et al.
Clinical Trials (London, England)|July 5, 2025
Dose finding in early-phase human immunodeficiency virus type 1 prevention monoclonal antibody clinical trialsYunda Huang, Bo Zhang, Lily Zhang, et al.
Retrovirology|July 11, 2008
Viral complementation allows HIV-1 replication without integrationHuub C Gelderblom, Dimitrios N Vatakis, Sean A Burke, et al.
Journal of the International AIDS Society|February 20, 2026
The HIV/AIDS response as we knew it is over: Where do we go from here?Chris Beyrer, Jirair Ratevosian, Tom Carpino, et al.
Iscience|September 1, 2023
Application of the SLAPNAP statistical learning tool to broadly neutralizing antibody HIV prevention researchBrian D Williamson, Craig A Magaret, Shelly Karuna, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Frontiers in Pediatrics|July 8, 2026
Breaking the sound barrier: global monoclonal antibody pharmacoequityHuub C Gelderblom, Glenda Gray, Brian Kelley
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 30, 2010
Transient reappearance of serum hepatitis C virus RNA observed by real-time PCR during antiviral therapy with peginterferon and ribavirin: Reappearance of references published in 2005-2009Huub C Gelderblom, Marcel G H M Beld
Journal of the International AIDS Society|May 17, 2024
The potential of broadly neutralizing antibodies for HIV preventionHuub C Gelderblom, Lawrence Corey, Dan H Barouch
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 30, 2007
Hepatitis C virus RNA quantification by the COBAS AmpliPrep/COBAS TaqMan System: averages do not tell the whole storyHuub C Gelderblom, Marcel G H M Beld
Plos Neglected Tropical Diseases|March 24, 2015
Mass drug administration for trachoma: how long is not long enough?Violeta Jimenez, Huub C Gelderblom, Rebecca Mann Flueckiger, et al.
Plos One|April 6, 2016
Diagnostic Accuracy of the HemoCue Hb 301, STAT-Site MHgb and URIT-12 Point-of-Care Hemoglobin Meters in a Central Laboratory and a Community Based Clinic in Durban, South AfricaManjeetha Jaggernath, Rumallen Naicker, Savathree Madurai, et al.
Clinical Trials (London, England)|July 5, 2025
Dose finding in early-phase human immunodeficiency virus type 1 prevention monoclonal antibody clinical trialsYunda Huang, Bo Zhang, Lily Zhang, et al.
Retrovirology|July 11, 2008
Viral complementation allows HIV-1 replication without integrationHuub C Gelderblom, Dimitrios N Vatakis, Sean A Burke, et al.
Journal of the International AIDS Society|February 20, 2026
The HIV/AIDS response as we knew it is over: Where do we go from here?Chris Beyrer, Jirair Ratevosian, Tom Carpino, et al.
Iscience|September 1, 2023
Application of the SLAPNAP statistical learning tool to broadly neutralizing antibody HIV prevention researchBrian D Williamson, Craig A Magaret, Shelly Karuna, et al.
Pageof 3